key: cord-0837109-6m5omyxs
authors: Keshavarz Valian, Nasrin; Pourakbari, Babak; Asna Ashari, Kosar; Hosseinpour Sadeghi, Reihaneh; Mahmoudi, Shima
title: Evaluation of human coronavirus OC43 and SARS‐COV‐2 in children with respiratory tract infection during the COVID‐19 pandemic
date: 2021-11-24
journal: J Med Virol
DOI: 10.1002/jmv.27460
sha: d9c084f37b8a6e39b6cfd455d6f4a33492a265f0
doc_id: 837109
cord_uid: 6m5omyxs

The coronavirus disease 2019 (COVID‐19) pandemic is an overwhelming crisis across the world. Human Coronavirus OC43 (HCoV‐OC43) is a Betacoronavirus responsible mostly for mild respiratory symptoms. Since the presentations of HCoV‐OC43 and severe acute respiratory syndrome coronavirus 2 (SARS‐COV‐2) are believed to resemble a lot, the aim of this study was to evaluate the frequency and characteristics of HCoV‐OC43 in the current pandemic and the rate of coinfection for the two viruses. One hundred and seventeen patients referred to Children's Medical Center, Tehran, Iran with respiratory symptoms were included. Real‐time reverse transcription‐polymerase chain reaction (RT‐PCR) methods were performed for the detection of HCoV‐OC43 and SARS‐COV‐2. Totally, 23 (20%) had a positive RT‐PCR for HCoV‐OC43 and 25 (21%) were positive for SARS‐COV‐2. Two patients (2%) had a positive PCR for both HCoV‐OC43 and SARS‐COV‐2. The two groups showed significant differences in having contact with family members with suspected or confirmed COVID‐19 (p = 0.017), fever (p = 0.02), edema (p = 0.036), vomiting (p < 0.001), abdominal complaints (p = 0.005), and myalgia (p = 0.02). The median level of lymphocyte count in patients with HCoV‐OC43 was significantly lower than patients with SARS‐COV‐2 infection (p = 0.039). The same frequency of SARS‐COV‐2 and HCoV‐OC43 was found in children with respiratory symptoms during the COVID‐19 pandemic. The rate of coinfection of SARS‐COV‐2 with HCoV‐OC43 in our study was 0.08. Further research into the cocirculation of endemic coronaviruses, such as HCoV‐OC43 and SARS‐CoV2, in different regions, is highly recommended. Attempts to determine the geographic distribution and recruit more flexible test panel designs are also highly recommended.

The Betacoronavirus (β-CoVs or Beta-CoVs) is one of the four genera of coronaviruses (Alpha, Beta, Gamma, and Delta). This genus is described as enveloped, positive-strand RNA viruses that infect mammals. 1 Their natural reservoirs are bats and rodents. 2, 3 Betacoronavirus genus contains four lineages: A, B, C, and D. The most common betacoronaviruses that can infect humans are HCoV-OC43 and HKU1 (which are believed to cause common cold symptoms) of lineage A, SARS-CoV, and SARS-CoV-2 (which has been found responsible for the current pandemic) of lineage B, and middle east respiratory syndrome coronavirus (MERS-CoV) of lineage C. HCoV-229E and HCoV-NL63 are the other coronaviruses associated with disease in humans, belonging to the Alpha genus, and are mostly known to cause mild respiratory symptoms. 4, 5 The suspected animal-to-human spread of four betacoronaviruses, including the HCoV-OC43 (1890), SARS-CoV-1 (2003), MERS-CoV (2012), and SARS-CoV-2(2019), proposes their high potential to cause pandemics. 6, 7 Limited papers have been published to date studying the coinfection of COVID-19 with other respiratory viruses. The most common reported coinfections are rhinovirus, enterovirus, influenza, respiratory syncytial virus, and non-SARS-CoV-2

Coronaviruses, including Coronavirus NL63, HKU1, 229E, and HCoV-OC43. [8] [9] [10] Strain HCoV-OC43 was found in 1967 in the nasopharynx of a patient with symptoms of a common cold. 1 Clinical manifestation reported in patients with HCoV-OC43 includes fever, rhinitis, pharyngitis, abdominal complaints, pneumonia, and less commonly, bronchitis, otitis, and laryngitis. 11 Lower tract respiratory manifestations can also be associated with HCoV-OC43 infection. Studies show that HCoV-OC43 infects the immunocompromised less than HKU1, 229E, and NL63 Coronaviruses. 12 Since the presentations of HCoV-OC43 and SARS-COV-2 resemble each other to a large extent, it is valuable to know the prevalence of HCoV-OC43 in the current pandemic and the rate of coinfection with SARS-CoV-2. Studying the morbidity and mortality of HCoV-OC43 infection can enlighten the burden of the disease and highlight the necessity of diagnostic investigations in approach to a patient with symptoms of COVID-19.

Mastering the knowledge of the pandemic's viral pathology helps address the correct approach to the disease and its treatment. Since the presentations of HCoV-OC43 and SARS-COV-2 are believed to resemble a lot, the aim of this study was to evaluate the frequency and characteristics of HCoV-OC43 in the current pandemic and the rate of coinfection for the two viruses.

This study received ethical approval (IR. TUMS. CHMC. REC.1399.097) from the Tehran University of Medical Sciences in Tehran, Iran. All participants gave written informed consent, and the study was carried out following the guidelines of the Declaration of Helsinki.

One hundred and seventeen children with suspected COVID-19 and respiratory symptoms were referred to Children's Medical Center, Tehran, Iran, between April 1 and July 30 of 2020. The specimens were collected via nasopharyngeal swabs and were kept in the freezer with a temperature of −20°C until tested.

The demographic data, including age and gender, and also clinical manifestations were gathered in a questionnaire. Fever, cough, sore throat, conjunctivitis, edema, tachypnea, chest pain, rhinorrhea, vomiting, headache, abdominal complaints, diarrhea, myalgia, and rash were among the clinical manifestations investigated. Laboratory evaluation included complete blood cell counts and their differentiation, inflammatory markers, including procalcitonin, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), electrolytes, and kidney and liver function tests.

Abnormal chest CT scan findings were considered as the most common and specific features found in COVID-19 patients, that is, peripheral, bilateral, ground-glass opacification (GGO) with or without consolidation or visible intralobular lines, multifocal ground-glass opacification or rounded morphology, or reverse halo sign or other findings of organizing pneumonia. 13, 14 The RNA of the collected samples was extracted using CinnaPure RNA Extraction Kit (SinaClone), following the manufacturer's guidelines, and complementary DNA (cDNAs) were then fabricated by First Strand cDNA Synthesis Kit (SinaClone). 15 Reverse transcription-polymerase chain reaction (RT-PCR) was performed for the detection of HCoV-OC43 and SARS-COV-2 using RNAse P as the housekeeping gene. 16, 17 Briefly, each reaction was performed in a 20 μl volume, which consisted Table 1 and compared with SARS-COV-2 and RT-PCRnegative groups.

In spite of the fact that fever, cough, conjunctivitis, edema, vomiting, abdominal complaints, diarrhea, headache, and myalgia were all more frequently observed in the patients with HCoV-OC43 infection rather than the PCR-negative group, the only significantly higher encountered symptoms in HCoV-OC43 patients were abdominal complaints (p=0.028). Symptoms found in HCoV-OC43positive patients are summarized in Table 2 

Since SARS-COV-2 shares clinical presentations with other respiratory viruses, and with special concern toward the critical circumstances of the COVID-19 pandemic, it is very important to describe the symptoms as much as possible and to perform highly accurate tests to distinguish the viruses, which necessitate urgent public health interventions and treatment.

HCoV-OC43 is a human infecting Coronavirus that is mostly known to cause mild respiratory symptoms. However, severe symptoms have also been reported in the literature. 11, 12 HCoV-OC43 cases in our study, also, showed low rates of severity, and no mortality was reported. It is noteworthy that before the current pandemic, SARS-COV-2 was indeed known to be mostly responsible for trivial respiratory symptoms, and no one expected such a tragedy on its behalf.

Although it is generally believed that SARS-COV-2, responsible for the current pandemic of COVID-19, resembles a lot in manifestations to HCoV-43, our study revealed that significant differences could be observed in manifestations of the two viruses, while the incidence of most of the symptoms of HCoV-OC43 was not significantly different with those of PCR-negative. Although it is widely assumed that SARS-COV-2, which is responsible for the current COVID-19 pandemic, closely resembles HCoV-43 in manifestations, our study found that significant differences in manifestations of the two viruses could be observed, while the frequency of most HCoV-OC43 symptoms was not significantly different from that of PCR-negatives. The symptoms of COVID-19 resemble a lot in children and adults, but the frequency differs. 21 In a report of 5188 confirmed cases of COVID-19 in the United States, the following symptoms were introduced as the most common: fever, cough, headache, sore throat, myalgia, dyspnea, diarrhea, nausea/vomiting, abdominal pain, rhinorrhea, and loss of smell or taste. 22 The frequency of symptoms in HCOV-OC43 is not thoroughly discussed in the literature. Vabret et al. described an outbreak of HCoV-OC43 in 2001 in Normandie, France. 11 The following frequencies were reported for HCOV-OC43 symptoms: fever in 60%, general symptoms (i.e., headache, anorexia, and myalgia) in 30%, digestive problems (i.e., emesis, diarrhea, and abdominal pain) in 56.7%, rhinitis in 36.7%, pharyngitis in 30%, laryngitis in 3.3%, otitis in 13.3%, and lower respiratory tract infection in nearly one-third of the patients.

In our study, the frequency of fever, headache, edema, vomiting, abdominal complaints, and myalgia was significantly higher in the KESHAVARZ VALIAN ET AL. Since the disease attack rate in children appears to have been changing since the start of the outbreak, updated studies should be conducted addressing the laboratory findings in children with COVID-19. 23 The importance of SARS-COV-2 and HCoV-OC43 cocirculation has been drawn into attention, especially during the COVID-19 pandemic.

Since there might be cross-reactivity between SARS-CoV-2 and endemic 

The authors declare that there are no conflict of interests.

All participants gave written informed consent, and the study was carried out following the guidelines of the Declaration of Helsinki. Valian and Babak Pourakbari contributed to data acquisition and data interpretation. Shima Mahmoudi contributed to the statistical analysis and revising of the manuscript. All authors reviewed and approved the final version.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

ORCID Shima Mahmoudi http://orcid.org/0000-0003-3557-6432

Epidemiology, genetic recombination, and pathogenesis of coronaviruses

On the origin and continuing evolution of SARS-CoV-2

Human coronavirus: host-pathogen interaction

Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease

Global patterns in coronavirus diversity

Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic

Human and novel coronavirus infections in children: a review. Paediatr Int Child Health

Rates of co-infection between SARS-CoV-2 and other respiratory pathogens

Coinfection in SARS-CoV-2 infected patients: where are influenza virus and rhinovirus/enterovirus?

The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan

An outbreak of coronavirus OC43 respiratory infection in Normandy, France

Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method

Novel coronavirus disease 2019 (COVID-19) outbreak in children in Iran: atypical CT manifestations and mortality risk of severe COVID-19 infection

The role of computed tomography scan in the diagnosis of COVID-19 pneumonia

Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran

Evaluation of custom multiplex real-time RT-PCR in comparison to fast-track diagnostics respiratory 21 pathogens kit for detection of multiple respiratory viruses

Analysis and forecasting of global real time RT-PCR primers and probes for SARS-CoV-2

Atypical and novel presentations of coronavirus disease 2019: a case series of three children

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

SARS-COV-2 infection in children and newborns: a systematic review

Coronavirus disease 2019 case surveillance-United States

Bibliography of published COVID-19 in children literature

Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study

Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19

CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope crossreact with selective seasonal coronaviruses

Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic

Coinfections with SARS-CoV-2 and other respiratory pathogens

Clinical evaluation of conventional human coronavirus infection in adults

Epidemiological and co-infection characteristics of common human coronaviruses in Shanghai, 2015-2020: a retrospective observational study

Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic

Evaluation of seasonal respiratory virus activity before and after the statewide COVID-19 shelter-in-place order in Northern California